Cullen/Frost Bankers Beats EPS but Misses Revenue; Shares Slip 0.8% in After‑Hours Trade
Cullen/Frost Bankers (NYSE:CFR) posted Q1 2026 earnings of $2.65 per share, topping the $2.46 consensus estimate, but revenue of $597 million fell short of the $585.3 million forecast. The results nudged the stock down 0.84% in after‑hours trading to $143.71, below Thursday’s close of $144.93.
Earnings Summary
- EPS: $2.65 vs. $2.46 estimate (beat by $0.19).
- Revenue: $597 M vs. $585.3 M estimate (reported as a miss in the filing).
- Net income: $169.3 M, up from $149.3 M a year ago.
- Net interest income: $460.8 M, a 5.6% YoY increase, pushing the net interest margin to 3.74% (up from 3.60% YoY).
- Non‑interest income: $136.3 M, up 9.9% YoY, driven by higher trust and investment‑management fees (+11.7%).
- Non‑interest expense: $365.7 M, up 5.1% YoY, reflecting higher salaries, benefits and cloud‑services costs.
- Credit loss expense: $6.7 M, down sharply from $13.1 M a year earlier, indicating a healthier loan portfolio.
Guidance & Outlook
CEO Phil Green highlighted the continued strength of the loan franchise – average loans rose 5.9% YoY to $22.0 B and deposits grew 1.4% YoY to $42.2 B. The firm announced a 3% dividend increase, taking the quarterly payout to $0.84 per share, underscoring confidence in cash flow generation. While the company did not issue a formal full‑year EPS target, management reaffirmed its expectation of “accretive earnings growth” as the Texas expansion reaches breakeven in the next 12‑18 months.
Conference Call Takeaways
- Branch expansion: The new Arboretum branch in Austin marks the 205th location, bringing total branch count up more than 50% since the 2018 Houston push.
- Regional momentum: Expansion locations in Houston, Dallas and Austin have already amassed $2.6 B in loans and $3.2 B in deposits.
- Capital strength: CET1, Tier 1 and total risk‑based capital ratios stand at 14.07%, 14.51% and 15.89% respectively, comfortably above Basel III minima.
- Fee growth: Investment‑management and deposit‑service fees rose double‑digits, offsetting modest pressure on interest‑sensitive margins.
Market Reaction
The earnings beat on EPS was not enough to offset the revenue miss and modest fee‑driven growth, leaving the stock down 0.84% in after‑hours trade to $143.71. Volume was light, suggesting the move was driven more by algorithmic re‑pricing than a broad sell‑off.
Analyst Commentary
- Nasdaq noted that CFR’s share price had just crossed above the 12‑month average analyst target of $139.00, indicating that many analysts still view the stock as undervalued despite the short‑term dip.
- MarketBeat highlighted the EPS beat and the dividend hike as positive signs, but warned that the revenue shortfall could temper enthusiasm until the next quarter’s loan‑growth trajectory is clearer.
- StockTitan emphasized the dividend increase, projecting that the higher payout could attract income‑focused investors and provide a floor for the share price.
Overall, Cullen/Frost’s solid loan growth and dividend raise provide a constructive backdrop, but the revenue miss and higher expense base keep the stock modestly pressured as investors await the next earnings update.
Outlook: With the Texas market still expanding and credit quality improving, the firm is positioned for incremental earnings upside. However, analysts will be watching Q2 loan‑originations and fee‑income trends closely to gauge whether the current growth rate can sustain the dividend hike and capital‑return strategy.
Key Takeaways
- EPS of $2.65 beat expectations by $0.19, but revenue missed consensus, pulling the stock down 0.84% to $143.71 in after‑hours trade.
- Loan portfolio grew 5.9% YoY to $22 B and deposits rose 1.4% YoY, supporting a net interest margin of 3.74%.
- Management announced a 3% dividend increase to $0.84 per share, signaling confidence in cash flow despite higher expenses.
- Branch expansion continued with the new Arboretum location, bringing total branches to 205 and boosting regional loan and deposit balances.
- Analysts remain cautiously optimistic; the stock traded above the average target price of $139, but revenue concerns keep short‑term sentiment muted.